JP2007536231A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007536231A5 JP2007536231A5 JP2007511450A JP2007511450A JP2007536231A5 JP 2007536231 A5 JP2007536231 A5 JP 2007536231A5 JP 2007511450 A JP2007511450 A JP 2007511450A JP 2007511450 A JP2007511450 A JP 2007511450A JP 2007536231 A5 JP2007536231 A5 JP 2007536231A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- methyl
- optionally
- alkoxy
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000000217 alkyl group Chemical group 0.000 claims 120
- 125000003545 alkoxy group Chemical group 0.000 claims 40
- -1 hydroxy, hydroxy Chemical group 0.000 claims 29
- 229910052739 hydrogen Inorganic materials 0.000 claims 25
- 239000001257 hydrogen Substances 0.000 claims 24
- 125000000623 heterocyclic group Chemical group 0.000 claims 23
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 21
- 150000002431 hydrogen Chemical class 0.000 claims 19
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 18
- 125000002252 acyl group Chemical group 0.000 claims 17
- 150000002825 nitriles Chemical class 0.000 claims 17
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 16
- 229910052736 halogen Inorganic materials 0.000 claims 15
- 150000002367 halogens Chemical class 0.000 claims 15
- 125000001072 heteroaryl group Chemical group 0.000 claims 15
- 125000003342 alkenyl group Chemical group 0.000 claims 14
- 125000003282 alkyl amino group Chemical group 0.000 claims 14
- 125000003118 aryl group Chemical group 0.000 claims 14
- 150000001875 compounds Chemical class 0.000 claims 14
- 125000004043 oxo group Chemical group O=* 0.000 claims 14
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 14
- 125000002757 morpholinyl group Chemical group 0.000 claims 13
- 125000003386 piperidinyl group Chemical group 0.000 claims 13
- 125000004076 pyridyl group Chemical group 0.000 claims 12
- 125000004663 dialkyl amino group Chemical group 0.000 claims 11
- 125000004193 piperazinyl group Chemical group 0.000 claims 11
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims 11
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 9
- 125000004423 acyloxy group Chemical group 0.000 claims 8
- 125000002883 imidazolyl group Chemical group 0.000 claims 8
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 claims 7
- 125000004442 acylamino group Chemical group 0.000 claims 7
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 7
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 claims 7
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 6
- 125000004656 alkyl sulfonylamino group Chemical group 0.000 claims 6
- 125000000304 alkynyl group Chemical group 0.000 claims 6
- 125000001425 triazolyl group Chemical group 0.000 claims 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 5
- 150000001356 alkyl thiols Chemical class 0.000 claims 5
- 150000001408 amides Chemical class 0.000 claims 5
- 125000003373 pyrazinyl group Chemical group 0.000 claims 5
- 125000002098 pyridazinyl group Chemical group 0.000 claims 5
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 claims 4
- 125000000842 isoxazolyl group Chemical group 0.000 claims 4
- 125000002971 oxazolyl group Chemical group 0.000 claims 4
- 125000003226 pyrazolyl group Chemical group 0.000 claims 4
- 125000000168 pyrrolyl group Chemical group 0.000 claims 4
- 125000000335 thiazolyl group Chemical group 0.000 claims 4
- 125000004568 thiomorpholinyl group Chemical group 0.000 claims 4
- WCNFFKHKJLERFM-UHFFFAOYSA-N thiomorpholinyl sulfone group Chemical group N1(CCSCC1)S(=O)(=O)N1CCSCC1 WCNFFKHKJLERFM-UHFFFAOYSA-N 0.000 claims 4
- ZCAGUOCUDGWENZ-UHFFFAOYSA-N thiomorpholinyl sulfoxide group Chemical group N1(CCSCC1)S(=O)N1CCSCC1 ZCAGUOCUDGWENZ-UHFFFAOYSA-N 0.000 claims 4
- 125000006559 (C1-C3) alkylamino group Chemical group 0.000 claims 3
- JNFIHXJPZSKVII-UHFFFAOYSA-N 1-methyl-7-pyridin-4-yloxyindole-2-carboxylic acid Chemical compound C=12N(C)C(C(O)=O)=CC2=CC=CC=1OC1=CC=NC=C1 JNFIHXJPZSKVII-UHFFFAOYSA-N 0.000 claims 3
- 125000004414 alkyl thio group Chemical group 0.000 claims 3
- 125000004069 aziridinyl group Chemical group 0.000 claims 3
- 125000002541 furyl group Chemical group 0.000 claims 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims 3
- 229910052757 nitrogen Inorganic materials 0.000 claims 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 125000001422 pyrrolinyl group Chemical group 0.000 claims 3
- 125000003831 tetrazolyl group Chemical group 0.000 claims 3
- 125000001113 thiadiazolyl group Chemical group 0.000 claims 3
- 125000001544 thienyl group Chemical group 0.000 claims 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 3
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims 2
- 125000005940 1,4-dioxanyl group Chemical group 0.000 claims 2
- KMTRUDSVKNLOMY-UHFFFAOYSA-N Ethylene carbonate Chemical compound O=C1OCCO1 KMTRUDSVKNLOMY-UHFFFAOYSA-N 0.000 claims 2
- YPWFISCTZQNZAU-UHFFFAOYSA-N Thiane Chemical compound C1CCSCC1 YPWFISCTZQNZAU-UHFFFAOYSA-N 0.000 claims 2
- 125000003435 aroyl group Chemical group 0.000 claims 2
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 claims 2
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 claims 2
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- 125000004276 dioxalanyl group Chemical group 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 claims 2
- 125000001041 indolyl group Chemical group 0.000 claims 2
- BXBOQEWXJKZESY-UHFFFAOYSA-N n-[3-(methanesulfonamido)-2-methoxy-5-(1-methylcyclopropyl)phenyl]-1-methyl-7-[2-(4-methylpiperazin-1-yl)pyridin-4-yl]oxyindole-2-carboxamide Chemical compound C1=C(C2(C)CC2)C=C(NS(C)(=O)=O)C(OC)=C1NC(=O)C(N(C1=2)C)=CC1=CC=CC=2OC(C=1)=CC=NC=1N1CCN(C)CC1 BXBOQEWXJKZESY-UHFFFAOYSA-N 0.000 claims 2
- 125000004593 naphthyridinyl group Chemical group N1=C(C=CC2=CC=CN=C12)* 0.000 claims 2
- 125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 claims 2
- 125000004309 pyranyl group Chemical group O1C(C=CC=C1)* 0.000 claims 2
- 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 claims 2
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 claims 2
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- HXJUTPCZVOIRIF-UHFFFAOYSA-N sulfolane Chemical compound O=S1(=O)CCCC1 HXJUTPCZVOIRIF-UHFFFAOYSA-N 0.000 claims 2
- 125000001412 tetrahydropyranyl group Chemical group 0.000 claims 2
- RAOIDOHSFRTOEL-UHFFFAOYSA-N tetrahydrothiophene Chemical compound C1CCSC1 RAOIDOHSFRTOEL-UHFFFAOYSA-N 0.000 claims 2
- ISXOBTBCNRIIQO-UHFFFAOYSA-N tetrahydrothiophene 1-oxide Chemical compound O=S1CCCC1 ISXOBTBCNRIIQO-UHFFFAOYSA-N 0.000 claims 2
- BUGOPWGPQGYYGR-UHFFFAOYSA-N thiane 1,1-dioxide Chemical compound O=S1(=O)CCCCC1 BUGOPWGPQGYYGR-UHFFFAOYSA-N 0.000 claims 2
- NNLBRYQGMOYARS-UHFFFAOYSA-N thiane 1-oxide Chemical compound O=S1CCCCC1 NNLBRYQGMOYARS-UHFFFAOYSA-N 0.000 claims 2
- YFHICDDUDORKJB-UHFFFAOYSA-N trimethylene carbonate Chemical compound O=C1OCCCO1 YFHICDDUDORKJB-UHFFFAOYSA-N 0.000 claims 2
- 125000004454 (C1-C6) alkoxycarbonyl group Chemical group 0.000 claims 1
- FFFYPQJYPMJWJY-UHFFFAOYSA-N 1-methyl-7-[2-(4-methylpiperazin-1-yl)pyridin-4-yl]oxyindole-2-carboxylic acid Chemical compound C1CN(C)CCN1C1=CC(OC=2C=3N(C)C(C(O)=O)=CC=3C=CC=2)=CC=N1 FFFYPQJYPMJWJY-UHFFFAOYSA-N 0.000 claims 1
- CDKZKAUOODOSCT-UHFFFAOYSA-N 1-methyl-7-[2-(4-methylpiperazin-1-yl)pyrimidin-4-yl]oxyindole-2-carboxylic acid Chemical compound C1CN(C)CCN1C1=NC=CC(OC=2C=3N(C)C(C(O)=O)=CC=3C=CC=2)=N1 CDKZKAUOODOSCT-UHFFFAOYSA-N 0.000 claims 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- 102000004127 Cytokines Human genes 0.000 claims 1
- 108090000695 Cytokines Proteins 0.000 claims 1
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 claims 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 125000005605 benzo group Chemical group 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000001786 isothiazolyl group Chemical group 0.000 claims 1
- 230000001404 mediated effect Effects 0.000 claims 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 claims 1
- SQLZBXYFLQKKFE-UHFFFAOYSA-N n-(2-tert-butyl-5-methoxypyridin-4-yl)-1-methyl-7-[2-(4-methylpiperazin-1-yl)pyrimidin-4-yl]oxyindole-2-carboxamide Chemical compound COC1=CN=C(C(C)(C)C)C=C1NC(=O)C1=CC2=CC=CC(OC=3N=C(N=CC=3)N3CCN(C)CC3)=C2N1C SQLZBXYFLQKKFE-UHFFFAOYSA-N 0.000 claims 1
- RGEHOVSPXMOFJS-UHFFFAOYSA-N n-(2-tert-butyl-5-methylsulfinylpyridin-4-yl)-1-methyl-7-[2-(4-methylpiperazin-1-yl)pyridin-4-yl]oxyindole-2-carboxamide Chemical compound C1CN(C)CCN1C1=CC(OC=2C=3N(C)C(C(=O)NC=4C(=CN=C(C=4)C(C)(C)C)S(C)=O)=CC=3C=CC=2)=CC=N1 RGEHOVSPXMOFJS-UHFFFAOYSA-N 0.000 claims 1
- FTPSXZOTFCPGEY-UHFFFAOYSA-N n-(5-tert-butyl-2-methylpyridin-3-yl)-1-methyl-7-[2-(4-methylpiperazin-1-yl)pyridin-4-yl]oxyindole-2-carboxamide Chemical compound C1CN(C)CCN1C1=CC(OC=2C=3N(C)C(C(=O)NC=4C(=NC=C(C=4)C(C)(C)C)C)=CC=3C=CC=2)=CC=N1 FTPSXZOTFCPGEY-UHFFFAOYSA-N 0.000 claims 1
- JGBCDDNLVNNVDP-UHFFFAOYSA-N n-(5-tert-butyl-2-methylpyridin-3-yl)-1-methyl-7-[2-(4-methylpiperazin-1-yl)pyrimidin-4-yl]oxyindole-2-carboxamide Chemical compound C1CN(C)CCN1C1=NC=CC(OC=2C=3N(C)C(C(=O)NC=4C(=NC=C(C=4)C(C)(C)C)C)=CC=3C=CC=2)=N1 JGBCDDNLVNNVDP-UHFFFAOYSA-N 0.000 claims 1
- PJQFFBWOBHJRSE-UHFFFAOYSA-N n-(5-tert-butyl-2-methylpyridin-3-yl)-1-methyl-7-pyridin-4-yloxyindole-2-carboxamide Chemical compound CC1=NC=C(C(C)(C)C)C=C1NC(=O)C1=CC2=CC=CC(OC=3C=CN=CC=3)=C2N1C PJQFFBWOBHJRSE-UHFFFAOYSA-N 0.000 claims 1
- FNYZOSLTEFIJEE-UHFFFAOYSA-N n-(5-tert-butyl-2-methylsulfinylphenyl)-1-methyl-7-pyridin-4-yloxyindole-2-carboxamide Chemical compound C=12N(C)C(C(=O)NC=3C(=CC=C(C=3)C(C)(C)C)S(C)=O)=CC2=CC=CC=1OC1=CC=NC=C1 FNYZOSLTEFIJEE-UHFFFAOYSA-N 0.000 claims 1
- RQKSFNAHXUEHEM-UHFFFAOYSA-N n-(5-tert-butyl-2-methylsulfonylphenyl)-1-methyl-7-pyridin-4-yloxyindole-2-carboxamide Chemical compound C=12N(C)C(C(=O)NC=3C(=CC=C(C=3)C(C)(C)C)S(C)(=O)=O)=CC2=CC=CC=1OC1=CC=NC=C1 RQKSFNAHXUEHEM-UHFFFAOYSA-N 0.000 claims 1
- QXMRVSNDXLZRDT-UHFFFAOYSA-N n-(5-tert-butyl-2-oxo-1h-pyridin-3-yl)-1-methyl-7-pyridin-4-yloxyindole-2-carboxamide Chemical compound C=12N(C)C(C(=O)NC=3C(NC=C(C=3)C(C)(C)C)=O)=CC2=CC=CC=1OC1=CC=NC=C1 QXMRVSNDXLZRDT-UHFFFAOYSA-N 0.000 claims 1
- VHPRXLOYYSAIRC-UHFFFAOYSA-N n-(5-tert-butyl-3-cyano-2-methoxyphenyl)-1-methyl-7-[2-(4-methylpiperazin-1-yl)pyridin-4-yl]oxyindole-2-carboxamide Chemical compound C1=C(C(C)(C)C)C=C(C#N)C(OC)=C1NC(=O)C1=CC2=CC=CC(OC=3C=C(N=CC=3)N3CCN(C)CC3)=C2N1C VHPRXLOYYSAIRC-UHFFFAOYSA-N 0.000 claims 1
- CWWSWNHORYIAPS-UHFFFAOYSA-N n-(5-tert-butyl-3-cyano-2-methoxyphenyl)-1-methyl-7-[2-(4-methylpiperazin-1-yl)pyrimidin-4-yl]oxyindole-2-carboxamide Chemical compound C1=C(C(C)(C)C)C=C(C#N)C(OC)=C1NC(=O)C1=CC2=CC=CC(OC=3N=C(N=CC=3)N3CCN(C)CC3)=C2N1C CWWSWNHORYIAPS-UHFFFAOYSA-N 0.000 claims 1
- KZPVENRWOMYPGP-UHFFFAOYSA-N n-(5-tert-butyl-3-cyano-2-methoxyphenyl)-1-methyl-7-pyridin-4-yloxyindole-2-carboxamide Chemical compound C1=C(C(C)(C)C)C=C(C#N)C(OC)=C1NC(=O)C1=CC2=CC=CC(OC=3C=CN=CC=3)=C2N1C KZPVENRWOMYPGP-UHFFFAOYSA-N 0.000 claims 1
- 125000001624 naphthyl group Chemical group 0.000 claims 1
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 1
- 230000000771 oncological effect Effects 0.000 claims 1
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 claims 1
- 150000003536 tetrazoles Chemical class 0.000 claims 1
- 150000003852 triazoles Chemical class 0.000 claims 1
- 0 Cc1c(*)c(C)cc(*)c1 Chemical compound Cc1c(*)c(C)cc(*)c1 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US56769304P | 2004-05-03 | 2004-05-03 | |
| US60/567,693 | 2004-05-03 | ||
| PCT/US2005/014947 WO2005108387A2 (en) | 2004-05-03 | 2005-04-29 | Cytokine inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007536231A JP2007536231A (ja) | 2007-12-13 |
| JP2007536231A5 true JP2007536231A5 (enExample) | 2008-06-19 |
| JP4865702B2 JP4865702B2 (ja) | 2012-02-01 |
Family
ID=35229785
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007511450A Expired - Fee Related JP4865702B2 (ja) | 2004-05-03 | 2005-04-29 | サイトカイン阻害剤 |
Country Status (5)
| Country | Link |
|---|---|
| US (3) | US7285545B2 (enExample) |
| EP (1) | EP1745036A2 (enExample) |
| JP (1) | JP4865702B2 (enExample) |
| CA (1) | CA2560387C (enExample) |
| WO (1) | WO2005108387A2 (enExample) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20060664A1 (es) | 2004-09-15 | 2006-08-04 | Novartis Ag | Amidas biciclicas como inhibidores de cinasa |
| US7531560B2 (en) * | 2004-11-10 | 2009-05-12 | Boehringer Ingelheim Pharmaceuticals, Inc. | Anti-cytokine heterocyclic compounds |
| WO2007056016A2 (en) * | 2005-11-02 | 2007-05-18 | Kemia, Inc. | Bisamide cytokine inhibitors |
| CN101365682A (zh) * | 2005-12-08 | 2009-02-11 | 千禧药品公司 | 具有激酶抑制活性的双环化合物 |
| JP5587914B2 (ja) | 2009-01-30 | 2014-09-10 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | キマーゼ阻害剤として有用なアザキナゾリンジオン |
| US9630896B2 (en) | 2013-11-22 | 2017-04-25 | Tansna Therapeutics, Inc. | 2,5-dialkyl-4-H/halo/ether-phenol compounds |
| SG11201700777VA (en) | 2014-08-04 | 2017-02-27 | Nuevolution As | Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases |
| MA52119A (fr) | 2015-10-19 | 2018-08-29 | Ncyte Corp | Composés hétérocycliques utilisés comme immunomodulateurs |
| PT3377488T (pt) | 2015-11-19 | 2022-11-21 | Incyte Corp | Compostos heterocíclicos como imunomoduladores |
| SI3394033T1 (sl) | 2015-12-22 | 2021-03-31 | Incyte Corporation | Heterociklične spojine kot imunomodulatorji |
| WO2017192961A1 (en) | 2016-05-06 | 2017-11-09 | Incyte Corporation | Heterocyclic compounds as immunomodulators |
| EP3464279B1 (en) | 2016-05-26 | 2021-11-24 | Incyte Corporation | Heterocyclic compounds as immunomodulators |
| CN109311848B (zh) | 2016-06-07 | 2022-02-01 | 北京加科思新药研发有限公司 | 可用作shp2抑制剂的新型杂环衍生物 |
| PL3472167T3 (pl) | 2016-06-20 | 2022-12-19 | Incyte Corporation | Związki heterocykliczne jako immunomodulatory |
| EP3484866B1 (en) | 2016-07-14 | 2022-09-07 | Incyte Corporation | Heterocyclic compounds as immunomodulators |
| ES2941716T3 (es) | 2016-08-29 | 2023-05-25 | Incyte Corp | Compuestos heterocíclicos como inmunomoduladores |
| CA3035308A1 (en) * | 2016-08-31 | 2018-03-08 | Taro Pharmaceutical Industries, Ltd. | Fenoldopam topical formulations for treating skin disorders |
| KR102696516B1 (ko) | 2016-12-22 | 2024-08-22 | 인사이트 코포레이션 | 면역조절제로서의 벤조옥사졸 유도체 |
| US20180179201A1 (en) | 2016-12-22 | 2018-06-28 | Incyte Corporation | Heterocyclic compounds as immunomodulators |
| EP3558973B1 (en) | 2016-12-22 | 2021-09-15 | Incyte Corporation | Pyridine derivatives as immunomodulators |
| MY197501A (en) | 2016-12-22 | 2023-06-19 | Incyte Corp | Tetrahydro imidazo[4,5-c]pyridine derivatives as pd-l1 internalization inducers |
| WO2018119286A1 (en) | 2016-12-22 | 2018-06-28 | Incyte Corporation | Bicyclic heteroaromatic compounds as immunomodulators |
| SMT202400385T1 (it) | 2017-03-23 | 2024-11-15 | Jacobio Pharmaceuticals Co Ltd | Nuovi derivati eterociclici utili come inibitori di shp2 |
| US10364245B2 (en) | 2017-06-07 | 2019-07-30 | Chiesi Farmaceutici S.P.A. | Kinase inhibitors |
| EP4212529B1 (en) | 2018-03-30 | 2025-01-29 | Incyte Corporation | Heterocyclic compounds as immunomodulators |
| FI4219492T3 (fi) | 2018-05-11 | 2025-02-17 | Incyte Corp | Heterosyklisiä yhdisteitä immunomodulaattoreina |
| US20210393623A1 (en) | 2018-09-26 | 2021-12-23 | Jacobio Pharmaceuticals Co., Ltd. | Novel Heterocyclic Derivatives Useful as SHP2 Inhibitors |
| WO2020183322A1 (en) | 2019-03-08 | 2020-09-17 | Taro Pharmaceutical Industries Ltd. | Stable topical compositions of fenoldopam |
| CA3150434A1 (en) | 2019-08-09 | 2021-02-18 | Incyte Corporation | Salts of a pd-1/pd-l1 inhibitor |
| AR120109A1 (es) | 2019-09-30 | 2022-02-02 | Incyte Corp | Compuestos de pirido[3,2-d]pirimidina como inmunomoduladores |
| IL292524A (en) | 2019-11-11 | 2022-06-01 | Incyte Corp | Salts and crystalline forms of a pd-1/pd-l1 inhibitor |
| TWI872177B (zh) | 2019-12-20 | 2025-02-11 | 丹麥商紐韋盧森公司 | 對核受體具有活性之化合物 |
| US11447479B2 (en) | 2019-12-20 | 2022-09-20 | Nuevolution A/S | Compounds active towards nuclear receptors |
| JP7713953B2 (ja) | 2020-03-31 | 2025-07-28 | ヌエヴォリューション・アクティーゼルスカブ | 核内受容体に対して活性な化合物 |
| CA3174176A1 (en) | 2020-03-31 | 2021-10-07 | Sanne Schroder Glad | Compounds active towards nuclear receptors |
| WO2022099075A1 (en) | 2020-11-06 | 2022-05-12 | Incyte Corporation | Crystalline form of a pd-1/pd-l1 inhibitor |
| PE20231438A1 (es) | 2020-11-06 | 2023-09-14 | Incyte Corp | Proceso para hacer un inhibidor de pd-1/pd-l1 y sales y formas cristalinas del mismo |
| US11780836B2 (en) | 2020-11-06 | 2023-10-10 | Incyte Corporation | Process of preparing a PD-1/PD-L1 inhibitor |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5744776A (en) * | 1989-07-14 | 1998-04-28 | Tip Engineering Group, Inc. | Apparatus and for laser preweakening an automotive trim cover for an air bag deployment opening |
| DE4302051A1 (de) | 1993-01-26 | 1994-07-28 | Thomae Gmbh Dr K | 5-gliedrige Heterocyclen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
| FR2732967B1 (fr) | 1995-04-11 | 1997-07-04 | Sanofi Sa | 1-phenylpyrazole-3-carboxamides substitues, actifs sur la neurotensine, leur preparation, les compositions pharmaceutiques en contenant |
| DE19546585A1 (de) * | 1995-12-13 | 1997-06-19 | Trw Repa Gmbh | Gassack-Abdeckung für ein Fahrzeuginsassen-Rückhaltesystem sowie Verfahren zu deren Herstellung |
| JP3430841B2 (ja) * | 1997-03-05 | 2003-07-28 | 豊田合成株式会社 | エアバッグカバー |
| EP1068187A1 (en) | 1998-04-08 | 2001-01-17 | Abbott Laboratories | Pyrazole inhibitors of cytokine production |
| EP1123287B1 (en) | 1998-10-23 | 2003-07-30 | Dow AgroSciences LLC | Insecticidal 3- (substituted pyridyl) -1, 2, 4-triazoles |
| GB9924092D0 (en) * | 1999-10-13 | 1999-12-15 | Zeneca Ltd | Pyrimidine derivatives |
| US6498423B1 (en) | 2001-06-27 | 2002-12-24 | Welch Allyn, Inc. | Lamp thermal control by directed air flow |
| WO2003022820A1 (en) | 2001-09-06 | 2003-03-20 | Bristol-Myers Squibb Pharma Company. | Heteroaromatic substituted cyclopropane as corticotropin releasing hormone |
| WO2003030902A1 (en) | 2001-10-09 | 2003-04-17 | Tularik Inc. | Imidazole derivates as anti-inflammatory agents |
| AU2003209388A1 (en) | 2002-01-29 | 2003-09-02 | Merck And Co., Inc. | Substituted imidazoles as cannabinoid receptor modulators |
| JP4578106B2 (ja) * | 2002-04-11 | 2010-11-10 | ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド | サイトカインインヒビターとしてのヘテロ環式アミド誘導体 |
| US7078419B2 (en) * | 2003-03-10 | 2006-07-18 | Boehringer Ingelheim Pharmaceuticals, Inc. | Cytokine inhibitors |
| ATE522525T1 (de) | 2003-05-01 | 2011-09-15 | Bristol Myers Squibb Co | Arylsubstituierte pyrazolamidverbindungen, die als kinase-inhibitoren von nutzen sind |
-
2005
- 2005-04-29 WO PCT/US2005/014947 patent/WO2005108387A2/en not_active Ceased
- 2005-04-29 CA CA2560387A patent/CA2560387C/en not_active Expired - Fee Related
- 2005-04-29 EP EP05745042A patent/EP1745036A2/en not_active Withdrawn
- 2005-04-29 US US11/119,524 patent/US7285545B2/en not_active Expired - Lifetime
- 2005-04-29 JP JP2007511450A patent/JP4865702B2/ja not_active Expired - Fee Related
-
2007
- 2007-08-15 US US11/839,136 patent/US20070275946A1/en not_active Abandoned
-
2008
- 2008-08-29 US US12/201,766 patent/US7592332B2/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007536231A5 (enExample) | ||
| ES2327940T3 (es) | 3-(4-heterociclil-1,2,3-triazol-1-il)-n-aril-benzamidas en calidad de inhibidores de la produccion de citocinas para el tratamiento de enfermedades inflamatorias cronicas. | |
| JP4865702B2 (ja) | サイトカイン阻害剤 | |
| CN102137666B (zh) | 化合物251 | |
| JP5432718B2 (ja) | ピロール化合物 | |
| ES2402362T3 (es) | Inhibidores de la bomba de protones | |
| JP5379690B2 (ja) | ５員複素環化合物 | |
| AU2004264409B2 (en) | Heterocyclic N-aryl carboxamides as cytokine inhibitors | |
| JP4035559B1 (ja) | 酸分泌抑制薬としての１−ヘテロシクリルスルホニル、２−アミノメチル、５−（ヘテロ−）アリール置換１−ｈ−ピロール誘導体 | |
| JP5225076B2 (ja) | チアゾール環を含むカルボン酸誘導体の医薬用途 | |
| ES2566772T3 (es) | Inhibidores de la quinasa c-fms | |
| JP5345140B2 (ja) | プロトンポンプ阻害剤としての５員複素環化合物 | |
| JP5480619B2 (ja) | ｃ−ｆｍｓキナーゼの阻害剤 | |
| JP2005509003A5 (enExample) | ||
| WO2007010965A1 (ja) | Ｐｇｄ２受容体アンタゴニスト活性を有するアザインドール酸誘導体 | |
| JP2007537255A5 (enExample) | ||
| TW204343B (enExample) | ||
| JP4939226B2 (ja) | チアゾール環を含むカルボン酸誘導体およびその医薬用途 | |
| JP2001072660A (ja) | ＴＮＦ−α産生抑制剤および／またはＩＬ−１０産生促進剤 | |
| JP2008510812A5 (enExample) | ||
| WO2006070806A1 (ja) | 新規ベンゾイミダゾール化合物及び該化合物を含有する医薬組成物 | |
| JP2008539181A (ja) | Ｅｐ１受容体アンタゴニストとして有用なフラン化合物 | |
| CA2577446A1 (en) | 2-arylcarbamoyl-indoles as cytokine inhibitors | |
| JP7616609B2 (ja) | Ｒｎａウイルス感染症を処置する為のアリール－ｎ－アリール誘導体 | |
| JP2013500310A (ja) | 抗腫瘍１，２−ジフェニルピロール化合物及びその調製方法 |